# drug discovery

From Public Rebuke to High‑Profile Hires: How Reputation and AI Are Reshaping China’s Corporate Playbook

A People’s Daily editorial has sounded a warning about the responsibilities of influential self‑media figures after a restaurant controversy, underscoring rising expectations for corporate and platform conduct. Concurrently, New Oriental’s hire of philanthropist Chen Xingjia and a string of AI partnerships in culture and biomedicine signal firms’ strategies to combine reputational capital with specialised, scenario‑driven AI deployments.